Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Hempdocon May 26, 2020 6:06pm
95 Views
Post# 31075374

RE:RE:RE:RE:WHO & The HCQ

RE:RE:RE:RE:WHO & The HCQ
Quattro74 wrote:
Hempdoc wrote: And giving such high doses at a more advanced stage of the illness is both irresponsible & inhumane imo.



Correct me please Doc,

HCQ is best given when symptoms first appear. To both block further entry into non infected cells, lowering viral load. And to suppress the immune system, which HCQ/Quinine do in larger doses, to lessen the cytokline storm. And this is just HCQ, not taking into account what Zn and Zpac bring? The idea that WHO is now against this makes me want to drive to Mexico and get some.


 

Well said Quattro...

IMO, HCQ will provide most benefit if used early or as a component of prophylaxis.  

HCQ is a weak base & this allows it to alkalinize (raise the pH) of acidic organelles (structures inside each cell that contain degrading enzymes).  This helps reduce viral replication.  Certainly, HCQ also reduces pro-inflammatory chemicals (called cytokines like IL-6) which participate in the cytokine storm that can occur in severely ill patients.  There are other more specific cytokine inhibitors (IL-6 inhibitors) that may work at least as well as HCQ against this storm (w/o the risks associated with high-dose HCQ).  There are also studies looking at lower-dose IL-6 given during less severe stages of illness which may also prove promising.  The jury is still out until we have more data re: the ideal/preferred drug, dosage & timing of dosage.  

So I think early use of HCQ will not only help prevent/treat cellular infection by the virus, but will also modulate the immune system to help prevent a cytokine storm from happening in the first place, or if given early enough during a storm, be more effective in reducing its progression.  IMO, high-dose HCQ given too late during a cytokine storm may increase cardiac events/toxicity & actually worsen one's s chances of survival.  This is not medical advice, but my guess is the best management would include lower-dose HCQ with Zinc + Azithromycin as outpatient therapy or immediately upon hospital admission.  For the more critically ill (or those with lab-determined elevation of cytokines), I would take full advantage of both specific cytokine inhibitors (IL-6 inhibitor) & general cytokine inhibition (w/preferably synergistic use of lower-dose HCQ ), other anti-virals (Remdesivir) & supportive care.

 

Bullboard Posts